Tomoya Sano, Keisuke Amano, Tatsuya Ide, Hiroshi Isoda, Yuichi Honma, Yasuyo Morita, Yoichi Yano, Hiroki Nakamura, Satoshi Itano, Ichiro Miyajima, et al. Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study. Hepatology research : the official journal of the Japan Society of Hepatology. 2023
Tomoya Sano, Keisuke Amano, Tatsuya Ide, Keiji Yokoyama, Kazunori Noguchi, Hiroki Nakamura, Hiroshi Isoda, Miki Ohno, Miki Shirachi, Yasuyo Morita, et al. A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus-related decompensated cirrhosis. Hepatology research : the official journal of the Japan Society of Hepatology. 2023. 53. 1. 26-34
Atsushi Takahashi, Hiromasa Ohira, Kazumichi Abe, Mikio Zeniya, Masanori Abe, Teruko Arinaga-Hino, Nobuhiro Nakamoto, Akinobu Takaki, Jong-Hon Kang, Satoru Joshita, et al. Risk factors for relapse of autoimmune hepatitis in Japan: A nationwide survey. Hepatology research : the official journal of the Japan Society of Hepatology. 2022. 52. 7. 597-602
Hiromasa Ohira, Atsushi Takahashi, Mikio Zeniya, Masanori Abe, Teruko Arinaga-Hino, Satoru Joshita, Akinobu Takaki, Nobuhiro Nakamoto, Jong-Hon Kang, Yoshiyuki Suzuki, et al. Clinical practice guidelines for autoimmune hepatitis. Hepatology research : the official journal of the Japan Society of Hepatology. 2022. 52. 7. 571-585
Teruko Arinaga-Hino, Tatsuya Ide, Jun Akiba, Hiroyuki Suzuki, Reiichiro Kuwahara, Keisuke Amano, Toshihiro Kawaguchi, Tomoya Sano, Eisuke Inoue, Hironori Koga, et al. Growth differentiation factor 15 as a novel diagnostic and therapeutic marker for autoimmune hepatitis. Scientific reports. 2022. 12. 1. 8759-8759